Abgent develops powerful tools to profile posttranslational modifications related to cellular function and disease. Abgent antibodies target protein kinases, phosphatases, methyl and acetyl transferases, ubiquitin and SUMO, glycosylases and other protein

http://www.abgent.com/phosphospecific

submitted on: 15-09-2008